Safety of HIV medications – new podcast out now

In focus / 04 May 2022

Henry Zakumumpa from Makerere University School of Public Health airs his research on HIV care and treatment strategies in Uganda and the need for more robust pharmacovigilance.


With the right care, people infected with HIV can lead long and healthy lives. But as with any life-long medical treatment, it is important to acknowledge and manage any side effects.  

In the latest episode of Drug Safety Matters, Henry Zakumumpa from Makerere University School of Public Health tells podcast host Federica Santoro about the potential harms of new HIV therapies and the challenges faced by pharmacovigilance specialists in Uganda. 

Subscribe by visiting the Drug Safety Matters website or listen in right here:

Related Articles

Orphan Drugs: Hope for rare disease communities

It takes a community to make medicines safer for all

New film shines a light on Colombia’s pharmacovigilance journey

You may also like

It takes a community to make medicines safer for all

The ‘PV in the Community’ special interest group explores how a community-focused approach can enhance medication safety and foster a more patient-centric pharmacovigilance system.

In focus / 10 March 2025

Orphan Drugs: Hope for rare disease communities

Orphan drug monitoring emerges as a critical lifeline for rare diseases, offering hope to patients with uncommon medical conditions.

In focus / 14 April 2025

New film shines a light on Colombia’s pharmacovigilance journey

The latest "WHO PIDM in Focus" film highlights the collaboration between WHO, UMC, and Colombia in the development of medicines and vaccines safety in the country.

In focus / 27 February 2025